Pharmacogenetics at 50: Genomic Personalization Comes of Age-Reference-Cited by-同舟云学术

Pharmacogenetics at 50: Genomic Personalization Comes of Age

Published:2014-01-22 Issue:220 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Urban Thomas J.¹,Goldstein David B.¹

Affiliation:

1. Center for Human Genome Variation, Duke University Medical Center, Durham, NC 27708, USA.

Abstract

In the past five decades, genetic studies of drug responses have provided few durable clinically relevant genetic markers, but current genomic technologies promise to increase the pace of such discoveries.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference79 articles.

1. Genome-wide association studies for complex traits: consensus, uncertainty and challenges

2. Uncovering the roles of rare variants in common disease through whole-genome sequencing

3. Genetic Mapping in Human Disease

4. Genome-wide association studies: potential next steps on a genetic journey

5. Genome-wide association studies: past, present and future

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PharmaKU: A Web-Based Tool Aimed at Improving Outreach and Clinical Utility of Pharmacogenomics;Journal of Personalized Medicine;2021-03-16

2. Pharmacometabolomics in Drug Discovery and Development;Systems Medicine;2021

3. The GenomeAsia 100K Project enables genetic discoveries across Asia;Nature;2019-12-04

4. Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population;Neuroscience Bulletin;2019-01-03

5. Applications of Metabolic Phenotyping in Pharmaceutical Research and Development;The Handbook of Metabolic Phenotyping;2019